The Zacks Analyst Blog Highlights: EGShares India Small Cap ETF, VanEck India Small Cap Index ETF, WisdomTree India Earnings Fund, Medtronic and Covidien
CHICAGO, Sept. 8, 2014 /PRNewswire/ -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the EGShares India Small Cap ETF (AMEX:SCIN-Free Report), VanEck India Small Cap Index ETF (AMEX:SCIF-Free Report), WisdomTree India Earnings Fund (AMEX:EPI-Free Report), Medtronic, Inc. (NYSE:MDT-Free Report) and Covidien plc (NYSE:COV-Free Report).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Friday's Analyst Blog:
India ETFs: Best of the BRICs Now?
The Indian stock market continues to defy skeptics as investors have been pouring money on hopes of structural reforms and economic rebound. Stocks' gains earlier this year were mainly driven by optimism over the new pro-reform, business-friendly government led by Prime Minister Narendra Modi.
After elections, Indian stocks took a breather for a little while as some investors looked for opportunities to book profits after a strong surge and some were disappointed by weaker-than-expected measures announced by the government in the budget. But that did not last long. (Read: 3 Ultra Cheap Value ETFs for Long Term Outperformance)
A positive earnings season and strong economic growth propelled the stock market into record territory again and many analysts now believe that Indian stocks are still attractive considering earnings' growth prospects in the coming years.
Improving Macroeconomic Conditions
During April-June fiscal quarter, Indian economy expanded by 5.7%--the best growth rate in two years, a with marked improvement in manufacturing and industrial production.
Inflation is now lowest in almost two years and slowly coming down towards central bank's target, thanks mainly to the aggressive steps taken by the central bank governor Raghuram Rajan last year and earlier this year.
Current account deficit has narrowed sharply with rising exports and declining imports. Restrictions imposed last year on gold imports have been the main contributor in bringing down the trade and current account deficits. (Read: Solar ETFs Hot Again, Brighter Days Ahead?)
Better-than-Expected Corporate Earnings
During the recent fiscal quarter (April-June), corporate earnings came in better-than-expected. Net profits of 30 largest companies grew 19% in the quarter. The auto industry is now witnessing a nice pick-up as the consumer sentiment has improved.
Financials' outlook is also more positive now as asset quality is expected to improve with the economy recovery. A large number of steps taken by the central bank towards making the financial sector healthier and more open have improved the long-term prospects for the sector. The energy sector should also improve with reforms being considered by the new government.
Reform Hopes
Stocks market gains in the coming months will depend on the government's policies and actions, as investors continue to pin hopes on reforms promised by the Modi government. (Read: 3 Growth ETFs to buy on large Cap Surge)
Strong steps towards improving infrastructure and manufacturing industry, encouraging foreign investments and introducing critical structural reforms would go a long way towards keeping investor hopes alive.
Further with a central bank committed to keeping inflation and current account deficit on track, India's long-term outlook certainly appears to be brightening.
What are the Risks?
Weaker-than-expected monsoon season in India has raised the risk of inflation picking up again. Further, the government is likely to cut spending as it struggles to bring the fiscal deficit down, which may hurt growth. At the same time economic growth may boost tax revenues, helping the government achieve its target of bringing down the fiscal deficit to 4.1% of GDP by the end of the current fiscal.
India is largely dependent on imports to meet its growing energy needs, leaving the economy vulnerable to any oil price shocks. Higher oil prices—resulting from escalation of tensions in the middle-east—could put some pressure on the recovery.
As the Fed is expected to start raising rates next year, many investors are concerned about the impact of higher rates in the US on emerging markets. However Indian stocks and the currency now seem much better positioned to withstand the shock.
A look at other Emerging Giants
At this time, India appears to be the only shining star among the group of emerging giants--popularly known as the BRICs.
China—the world's second largest economy continues to face headwinds--raising doubts whether it will "manage" to achieve its growth target of 7.5% this year. The health of its financial system also remains a big concern in the mind of investors.
Brazil's economy has already suffered two consecutive quarters of contraction and the recent data points to continued weakness in the current quarter as well. The only silver lining there is the dimming hope for President Dilma Rousseff's re-election.
Russian stocks look enticingly cheap to some but given enormously high level of political risk, they are suitable for dare-devil investors only. Further the Russian economy looks quite weak as of now.
ETFs to Consider
ETFs focusing on small cap stocks—EGShares India Small Cap ETF (AMEX:SCIN-Free Report) and VanEck India Small Cap Index ETF (AMEX:SCIF-Free Report)—were big winners earlier this year but have underperformed the large cap India ETFs in the last couple of months. They look attractive for long-term investment, given their focus on the growing middle class in India. Further, they are more immune to global economic twists and turns compared to their large cap cousins.
Investors should also look at WisdomTree India Earnings Fund (AMEX:EPI-Free Report) which holds profitable companies using an earnings-weighted methodology. Its focus on cyclical and some exposure to small cap stocks make it well positioned to benefit from the recent positive trends.
Medtronic Poised on Improved Q1, Covidien Buyout
On Sep 5, 2014, we issued an updated research report on Medtronic, Inc. (NYSE:MDT-Free Report). Although the company reported lower ICD revenues in the fiscal first quarter, prior to the launch of new products, the company's decision of shifting its tax base overseas through the $43 billion mega acquisition of Covidien plc (NYSE:COV-Free Report) should prove materially positive for the company in the coming period. The stock currently carries a Zacks Rank #3 (Hold).
Medtronic posted better-than-expected results for its first-quarter of fiscal 2015 with adjusted earnings per share of 93 cents, up 5.7% year over year, beating the Zacks Consensus Estimate by a penny. Revenues came in at $4.273 billion, up 4.7% at CER, marginally ahead of the Zacks Consensus Estimate of $4.249 billion. The company expects a pickup in the ICD revenues with new product launch, going forward.
We are also encouraged with the company's acquisition decision of its Irish rival Covidien to offset the impact of a high U.S. corporate tax rate by shifting its tax base overseas. The deal, valued at $42.9 billion, also marks a solid step toward establishing Medtronic as the world's leading medical technology and services company in over 150 countries. Post-acquisition, the combined entity would generate about $27 billion in total revenue, including $3.7 billion from emerging markets. It is also expected to prove accretive to cash earnings in 2016 and beyond.
Medtronic is also resorting to all possible means to boost growth. This includes penetration into emerging markets, expansion of portfolio and restructuring of initiatives, which should benefit the company over the long term.
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.
Get the full Report on SCIN - FREE
Get the full Report on SCIF - FREE
Get the full Report on EPI - FREE
Get the full Report on MDT - FREE
Get the full Report on COV - FREE
Follow us on Twitter: http://twitter.com/zacksresearch
Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Logo - http://photos.prnewswire.com/prnh/20101027/ZIRLOGO
SOURCE Zacks Investment Research, Inc.
Share this article